Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Generic pharmaceuticals company Actavis Group has received approval from the US Food and Drug Administration to market alprazolam ER tablets.
Subscribe to our email newsletter
Actavis said distribution of the product would commence in coming weeks.
Alprazolam ER tablets are the generic equivalent of Pfizer's Xanax XR tablets, will be available in 0.5mg, 1mg, 2mg, and 3mg strengths. Alprazolam ER tablets are indicated for the treatment of anxiety and panic disorder.
Annual sales of alprazolam ER tablets in the US were approximately $53.9 million for the twelve months ending December 2006 according to IMS Health data.